Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
nominal sampling time | planned or protocol time rather than the confirmed collection time | Nominal sampling time was listed separately from the actual phlebotomy time. | Assessment | Medication response, exposure and reconciliation |
nonimmune intolerance | unwanted effect without evidence of an immune-mediated mechanism | Nonimmune intolerance was recorded for isolated dose-related nausea. | Assessment | Medication response, exposure and reconciliation |
nonrenal clearance | drug elimination through routes other than the kidneys | The review considered a change in nonrenal clearance during the acute illness. | Assessment | Drug concentrations, exposure and assay interpretation |
norclozapine | clozapine metabolite measured in some monitoring panels | The norclozapine result is listed with its own units. | Objective | Drug levels - named analytes and exposure reports |
nortriptyline | tricyclic antidepressant measurable in blood | The nortriptyline report gives the specimen time relative to the last dose. | Objective | Drug levels - named analytes and exposure reports |
observed-to-predicted ratio | measured value divided by the model prediction at that time | The observed-to-predicted ratio was recalculated after the collection time was corrected. | Assessment | Drug concentrations, exposure and assay interpretation |
occupational | associated with the work environment | Reports occupational exposure to airborne dust. | Subjective | Sequence, exposures and use of medicines |
omitted home medication | usual home medicine absent from the current list or orders | Omitted home medication was identified when the caregiver brought the pill bottles. | Assessment | Medication response, exposure and reconciliation |
opioid rotation | change from one opioid to another for a stated clinical goal | Opioid rotation was reviewed with the prior formulation and actual use recorded. | Assessment | Medication response, exposure and reconciliation |
ototoxicity | harmful effect on hearing or vestibular function | The hearing change raises concern for possible ototoxicity. | Assessment | Medication exposure, response and adverse-effect reasoning |
out-of-window sample | sample collected outside the timing window specified for interpretation | The out-of-window sample was retained with the actual time and the intended sampling window. | Assessment | Medication response, exposure and reconciliation |
over-the-counter | available without a prescription | Reports using an over-the-counter sleep aid on work nights. | Subjective | Sequence, exposures and use of medicines |
overdose | quantity taken exceeds the intended dose as established by history or assessment | The history does not establish an overdose from the elevated concentration alone. | Assessment | Medication exposure, response and adverse-effect reasoning |
overnight | during the night | Reports two episodes of vomiting overnight. | Subjective | Sequence, exposures and use of medicines |
oxcarbazepine | antiseizure agent commonly monitored through its active monohydroxy metabolite | The order names oxcarbazepine and the report identifies its measured metabolite. | Objective | Drug levels - named analytes and exposure reports |
paired peak and trough | two concentrations intended to represent different points of one dosing interval | Paired peak and trough were interpreted after confirming both belonged to the same interval. | Assessment | Medication response, exposure and reconciliation |
parent-to-metabolite ratio | parent drug concentration divided by the measured metabolite concentration | The parent-to-metabolite ratio was recorded with both analytes and collection times. | Assessment | Medication response, exposure and reconciliation |
partial AUC | area under the concentration-time curve over a defined subinterval | The partial AUC was reported for the first four hours with the interval specified. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough fluctuation | extent of change between highest and lowest concentrations across a dosing interval | The report defines the calculation used for peak-to-trough fluctuation. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough ratio | peak concentration divided by trough concentration for the stated interval | The peak-to-trough ratio uses two results from the same dosing interval. | Assessment | Drug concentrations, exposure and assay interpretation |
perimenstrual | around the time of menstruation | Reports perimenstrual worsening of cramps. | Subjective | Sequence, exposures and use of medicines |
persisted | continued during the stated interval | Reports that aching persisted for two days after the hike. | Subjective | Sequence, exposures and use of medicines |
pharmacodynamic interaction | combined drug effects without necessarily changing concentration | The review considers a pharmacodynamic interaction as a contributor to sedation. | Assessment | Medication exposure, response and adverse-effect reasoning |
pharmacokinetic interaction | one drug changes another's absorption, distribution or clearance | The pharmacist assessed a possible pharmacokinetic interaction after the formulation change. | Assessment | Medication exposure, response and adverse-effect reasoning |
pharmacologic antagonism | one medicine opposes the action of another | Pharmacologic antagonism may explain the change after the second agent was started. | Assessment | Medication response, exposure and reconciliation |